Physician profile
Paul Eugene Reckard
NPI 1902823578
$2,090.78
in general payments reported to CMS, 2019-2025
8 companies · $1,648 in 2025
The $1,648 reported for 2025 was more than what 75% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2021: $292 · 2022: $14.33 · 2025: $1,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,280 · Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,280.17 |
| Food and Beverage | $368.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,648.29 | 2025 | Pivox Oblique Lateral Spinal System, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Intuitive Surgical, INC. | $120.29 | 2019 | |
| Karl Storz Endoscopy-America | $114.70 | 2021 | |
| Stryker Corporation | $112.36 | 2021 | |
| Zimmer Biomet Holdings, INC. | $64.81 | 2021 | |
| Z-Medica, LLC | $16.00 | 2019 | |
| Innovation Technologies INC | $14.33 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Reckard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.